GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Plandai Biotechnology Inc (OTCPK:PLPL) » Definitions » EBIT per Share

Plandai Biotechnology (Plandai Biotechnology) EBIT per Share : $-0.00 (TTM As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is Plandai Biotechnology EBIT per Share?

Plandai Biotechnology's EBIT per Share for the six months ended in Jun. 2023 was $-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Plandai Biotechnology's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Plandai Biotechnology was 86.70% per year. The lowest was -24.40% per year. And the median was 44.10% per year.

PLPL's 3-Year EBIT Growth Rate is not ranked *
in the Diversified Financial Services industry.
Industry Median: 7.9
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Plandai Biotechnology's EBIT for the six months ended in Jun. 2023 was $-19.77 Mil.


Plandai Biotechnology EBIT per Share Historical Data

The historical data trend for Plandai Biotechnology's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plandai Biotechnology EBIT per Share Chart

Plandai Biotechnology Annual Data
Trend Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.13 -0.08 -0.02 - -

Plandai Biotechnology Semi-Annual Data
Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.13 -0.08 -0.02 - -

Plandai Biotechnology EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Plandai Biotechnology's EBIT per Share for the fiscal year that ended in Jun. 2023 is calculated as

EBIT per Share(A: Jun. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=-19.773/7569.871
=-0.00

Plandai Biotechnology's EBIT per Share for the quarter that ended in Jun. 2023 is calculated as

EBIT per Share(Q: Jun. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=-19.773/7569.871
=-0.00

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Plandai Biotechnology  (OTCPK:PLPL) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Plandai Biotechnology EBIT per Share Related Terms

Thank you for viewing the detailed overview of Plandai Biotechnology's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Plandai Biotechnology (Plandai Biotechnology) Business Description

Traded in Other Exchanges
N/A
Address
4811 49th Street, San Diego, CA, USA, 92115
Plandai Biotechnology Inc. manufactures highly bioavailable extracts from live plant materials.
Executives
Callum Baylis-duffield director FLAT 37 ISLAND HOUSE THREE MILL LANE, LONDON ENGLAND X0 E33AF
Timothy Matula other: Former Director 175 JACKSON AVE N, SUITE 102, MINNEAPOLIS MN 55343
Brian Johnson director P.O. BOX 1594, FERNDALE WA 98248-1594
Roger Duffield director, officer: President, Secretary and CFO 2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
Daron Baylis Duffield director 2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
David Rzepnicki director 21 HORIZON DRIVE, SARATOGA SPRINGS NY 12866